acute myeloid leukemia (AML) | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

2021 March for Marrow California - Virtual Walk and 5K

Help us continue to support the patients served by AAMDSIF by registering to run in our 2021 Virtual Walk and 5K or simply by donating. We look forward to walking and running with you the week of April 24 - May 1, 2021, and continuing the celebration of the brave patients and families that are fighting

Event Date: 
Sat, 04/24/2021 (All day) to Sat, 05/01/2021 (All day)
Community Event Type: 

Young Adult Patient Virtual Support Group

Event Date: 
Tue, 03/30/2021 - 7:00pm

This virtual support group is to help support patients between the ages of 18-30 who have been diagnosed with

Jenna Moran, MSN, FNP-BC

Moran, Jenna
Oncology Nurse Practitioner
Massachusetts General Hospital Cancer Center

Jenna Moran, MSN, FNP-BC, is an oncology nurse practitioner with the Leukemia department at the Massachusetts General Hospital Cancer Center in Boston, MA. She has experience in both the ambulatory and inpatient care settings. Her current areas of clinical focus include

Aura Ramos, RN, BSN

Ramos, Aura
Leukemia Research Nurse
Massachusetts General Hospital Cancer Center

Aura Ramos, RN, BSN, is a leukemia research nurse at the Massachusetts General Hospital Cancer Center in Boston for the past 6 years.  Aura has over 16 years of nursing experience caring for oncology patients in the ambulatory and inpatient setting. Prior to becoming a research nurse, she worked as a staff nurse on the leukemia and

SY-1425

SY-1425 is a selective retinoic acid receptor alpha (RARα) agonist for genomically defined subsets of patients whose disease is characterized by the overexpression of the RARA gene. SY-1425 is in clinical trials for RARA-positive patients.

Share with addtoany.com.